TrialBlood advances2020

Ixazomib, dexamethasone, and rituximab in treatment-naive patients with Waldenström macroglobulinemia: long-term follow-up.

Jorge J Castillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.